ADI Announces U.S. FDA 510(k) Clearance and the Commercial Launch of Sensinel by Analog Devices™ Cardiopulmonary Management (CPM) System
Enabling closer remote patient monitoring and reduced healthcare costs India, March 06, 2024—– Analog Devices, Inc. (Nasdaq: ADI) has announced...
